|
SNRNP48 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.8790999999947E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.39509999999665E-05 |
| Normal-vs-Stage2 |
1.594980E-01 |
| Normal-vs-Stage3 |
2.084800E-03 |
| Normal-vs-Stage4 |
2.711800E-01 |
| Stage1-vs-Stage2 |
4.498000E-01 |
| Stage1-vs-Stage3 |
9.326800E-01 |
| Stage1-vs-Stage4 |
4.253000E-01 |
| Stage2-vs-Stage3 |
5.953800E-01 |
| Stage2-vs-Stage4 |
8.783200E-01 |
| Stage3-vs-Stage4 |
4.461200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.29749999999651E-05 |
| Normal-vs-AfricanAmerican |
1.450130E-02 |
| Normal-vs-Asian |
1.959780E-02 |
| Caucasian-vs-AfricanAmerican |
5.848800E-01 |
| Caucasian-vs-Asian |
6.676400E-01 |
| AfricanAmerican-vs-Asian |
4.766000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.02529999999701E-05 |
| Normal-vs-Female |
2.021600E-02 |
| Male-vs-Female |
2.921600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.554600E-04 |
| Normal-vs-Extreme_Weight |
3.90719999999734E-05 |
| Normal-vs-Obese |
2.189700E-02 |
| Normal-vs-Extreme_Obese |
1.076190E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.307000E-01 |
| Normal_Weight-vs-Obese |
2.209000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.024800E-01 |
| Extreme_Weight-vs-Obese |
9.777700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.870400E-01 |
| Obese-vs-Extreme_Obese |
2.093600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.189560E-02 |
| Normal-vs-Age(41-60Yrs) |
6.517500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.96990000037134E-07 |
| Normal-vs-Age(81-100Yrs) |
4.982000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.485600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.237800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.115200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.619300E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.824500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.314400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.758600E-04 |
| Normal-VS-Type2 PRCC |
1.75790000001008E-07 |
| Normal-VS-KIRP CIMP |
1.610590E-01 |
| Normal-VS-Unclassified PRCC |
7.946100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.497400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.828600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.937600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.804600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.045830E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.659600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.18139999996758E-06 |
| Normal-vs-N1 |
3.019200E-01 |
| Normal-vs-N2 |
4.440300E-03 |
| N0-vs-N1 |
1.130430E-02 |
| N0-vs-N2 |
5.116400E-01 |
| N1-vs-N2 |
1.443550E-01 |
|
|
